Brokerages Set Amrize Ltd (NYSE:AMRZ) Price Target at $60.00

Shares of Amrize Ltd (NYSE:AMRZGet Free Report) have received an average rating of “Moderate Buy” from the fifteen analysts that are covering the firm, MarketBeat Ratings reports. Seven research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $60.00.

Several equities analysts have commented on AMRZ shares. Zacks Research upgraded shares of Amrize from a “strong sell” rating to a “hold” rating in a research note on Friday, October 10th. Kepler Capital Markets raised Amrize to a “strong-buy” rating in a research note on Tuesday, October 21st. Vertical Research assumed coverage on Amrize in a report on Tuesday, November 25th. They set a “hold” rating and a $54.00 price target on the stock. Weiss Ratings reiterated a “hold (c+)” rating on shares of Amrize in a research note on Tuesday. Finally, Wells Fargo & Company boosted their price objective on Amrize from $57.00 to $58.00 and gave the stock an “overweight” rating in a research report on Thursday, October 30th.

Read Our Latest Stock Analysis on Amrize

Amrize Price Performance

Shares of NYSE:AMRZ opened at $55.85 on Friday. The stock has a market capitalization of $30.89 billion and a price-to-earnings ratio of 30.35. Amrize has a 1 year low of $44.12 and a 1 year high of $56.76. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.38 and a quick ratio of 0.85. The stock’s 50-day simple moving average is $51.46.

Amrize (NYSE:AMRZGet Free Report) last posted its quarterly earnings data on Wednesday, October 29th. The company reported $0.98 EPS for the quarter, missing the consensus estimate of $1.01 by ($0.03). The firm had revenue of $3.68 billion for the quarter, compared to analyst estimates of $3.49 billion. The firm’s revenue for the quarter was up 6.6% on a year-over-year basis.

Insider Activity

In other news, Director Nicholas C. Gangestad acquired 2,000 shares of the company’s stock in a transaction on Wednesday, November 19th. The shares were bought at an average cost of $47.34 per share, with a total value of $94,680.00. Following the transaction, the director owned 4,958 shares in the company, valued at approximately $234,711.72. This trade represents a 67.61% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Jan Philipp Jenisch acquired 55,000 shares of Amrize stock in a transaction dated Thursday, October 30th. The stock was purchased at an average price of $52.64 per share, for a total transaction of $2,895,200.00. Following the completion of the acquisition, the chief executive officer directly owned 1,505,000 shares in the company, valued at approximately $79,223,200. This represents a 3.79% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last 90 days, insiders purchased 65,000 shares of company stock valued at $3,399,720.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. State of Wyoming purchased a new stake in Amrize during the third quarter worth approximately $32,000. US Bancorp DE acquired a new stake in Amrize during the third quarter worth approximately $38,000. Costello Asset Management INC acquired a new stake in Amrize during the third quarter worth approximately $44,000. Global Retirement Partners LLC purchased a new stake in shares of Amrize during the 3rd quarter worth approximately $48,000. Finally, Jones Financial Companies Lllp acquired a new position in shares of Amrize in the 3rd quarter valued at $53,000.

Amrize Company Profile

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Further Reading

Analyst Recommendations for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.